Close
Help





JOURNAL

Clinical Medicine Reviews in Vascular Health

Dronedarone and Atrial Fibrillation: A Critical Review

Submit a Paper


Clinical Medicine Reviews in Vascular Health 2010:2

Review

Published on 20 Jul 2010

DOI: 10.4137/CMRVH.S4703


Further metadata provided in PDF

Download Article PDF


Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Vascular Health

Abstract

The recent approval of dronedarone by the Food and Drug Administration has expanded the list of drugs available for the treatment of atrial fibrillation (AF). Despite wide-spread attention, the future of this antiarrhythmic compound remains uncertain. The aim of this review is to examine the major clinical trials that have evaluated dronedarone in human subjects and provide a practical framework for its use among patients with AF.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services